FDA to Speed Up Review of Novel CAR-T Cell Therapy for Rare Forms of Lymphoma and Leukemia The Food and Drug Administration (FDA) granted a fast track designation to an investigational CAR-T cell therapy, WU-CART-007, for the treatment of relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL)/lymphoblastic lymphoma (LBL), according
Scientists Develop Blueprint for Turning Stem Cells into Sensory Interneurons Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a first-of-its-kind roadmap detailing how stem cells become sensory interneurons—the cells that enable sensations like touch, pain and itch. Read more...
SLU Researcher Helps Develop Treatment for a Type of Incurable Liver Disease White blood cells are so powerful that when they’re sent out to fight off an infection, the body produces a type of protein to protect the tissue of the lungs and other organs from being damaged. For people
MU Researchers Discover Breakthrough Information About Omicron Sub Variants According to a press release on Monday morning, researchers at the University of Missouri have identified new information amid the sweep of new Omicron sub-variants of COVID-19. Read more...
Kansas City Scientist Finds Proteins in the Brain Can Do More than Cause Alzheimer's Disease A Stowers Institute researcher intent on learning how our brains work found that proteins can have more than one effect on what we remember. Read more...
COVID-19 Vaccines May Temporarily Cause Changes to Menstrual Bleeding There have been tens of thousands of reports of changes to menstrual cycles worldwide following COVID-19 vaccination, but a link has not yet been proven or disproven. This is partly due to the failure of pharmaceutical companies to include questions about
Edits to a Cholesterol Gene Could Stop the Biggest Killer on Earth A volunteer in New Zealand has become the first person to undergo DNA editing in order to lower their blood cholesterol, a step that may foreshadow wide use of the technology to prevent heart attacks. Read more...
Silviya Petrova Zustiak, Ph.D. Meet Silviya Petrova Zustiak, Ph.D., Associate Professor of Biomedical Engineering; Co-Director, Institute of Drug and Biotherapeutic Innovation at SLU and Associate Professor of Pharmacology and Physiology. Dr. Petrova Zustiak’s primary research interests are in hydrogel biomaterials and tissue engineering. Her research is highly
The First CRISPR Gene-Editing Drug is Coming — Possibly as Soon as Next Year Until recently, CRISPR—the gene-editing technology that won scientists Jennifer Doudna and Emmanuelle Charpentier the 2020 Nobel Prize in chemistry—sounded more like science fiction than medicine; lab-created molecular scissors are used to snip out problematic DNA sections
